Clinical Trials Directory

Trials / Completed

CompletedNCT00621426

T-Wave Alternans in Dialysis Patients

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Northwestern University · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Sudden cardiac death due to arrhythmia is the leading cause of death in end-stage renal disease (ESRD) patients treated with hemodialysis (HD). As it is anticipated that the number of individuals with ESRD will exceed 1.2 million in the next 20 years, sudden death in this population has enormous public health impact. Research has shown that arrhythmic events are temporally associated with longer periods between HD with a three-fold risk of events in the 12 hours preceding the longest inter-dialysis interval. The exact cause of these findings is unknown.

Detailed description

The purpose of this study is to assess the degree of cardiac electrical instability at various times in the dialysis cycle. The hypothesis is that longer time intervals between hemodialysis results in sympathetic and electrolyte-induced alterations in ventricular repolarization that can be measured non-invasively using microvolt T-wave alternans (TWA). This increase in cardiac electrical instability may serve as a link between the clinically observed periods of increased risk and the occurrence of sudden cardiac death.

Conditions

Timeline

Start date
2007-04-01
Primary completion
2008-05-01
Completion
2008-05-01
First posted
2008-02-22
Last updated
2015-03-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00621426. Inclusion in this directory is not an endorsement.

T-Wave Alternans in Dialysis Patients (NCT00621426) · Clinical Trials Directory